The preliminary comparative phosphoproteomics experiment using six mice was presented as poster ThP-437 at the 57th American Society for Mass Spectrometry Conference on June 4, 2009 in Philadelphia, PA, and is available at asms.org.
Raw spectra are available for download as .RAW files at the Proteome Commons Tranche data repository at https://proteomecommons.org/ (Tranche Hash: j7rN4iodsyEQbWjTaWAqMthHEdlfsCqJc/WeLuA5xsrD0Tiu7NOEAwQWpWxhpAwl+hRPiBRzsc+K 0cTFg2Kipfp+LDEAAAAAAAA9rw==).
Annotated spectra are available for download as a 212 MB .zip file at the Proteome Commons Tranche data repository at https://proteomecommons.org/ (Tranche Hash: WsVcA7Y8lkPS/nO8sWIQTueMRiq6z6Vf4ZQRPSfLyH++tSbSXEAWCjHI+gxw2usbd+7ezHNKgete v8nSCyPBln/PDcoAAAAAAAAETg==).
Supplemental Figure 1. Systematic Precursor Ion Mass Measurement Error
Top: Each Mascot and SEQUEST dataset underwent preliminary filtration and then the mean precursor ion mass error (observed mass -theoretical mass) was determined within five m/z bins. Phosphopeptide identifications (black squares; the red line is the moving average) were discarded if their precursor ion mass error exceeded filtration criteria (blue lines = the mean error +/-3.5 ppm). In this way, the search space was reduced from 20 ppm to 7 ppm. This plot is of SEQUEST data from one of the LC-MS datasets. Bottom: The corresponding data from a decoy database (scrambled) search.
Supplemental Figure 2. A Discriminant Analysis using Phosphopeptide FDR Estimator
Top: A histogram of the discriminant score distribution for one of the LC-MS datasets. The discriminant analysis successfully discriminated between the two populations of identifications. Bottom: The corresponding estimates of p (p-value), q (q-value which is the percentage of falsely identified phosphopeptides), p(+|F) (the probability that the identification is correct), and FNR (the percentage of false negative identifications). See Du et al 2008 J Proteome Res 7(6):2195-203 for a description of Phosphopeptide FDR Estimator.
Supplemental Figure 5. SICs of One of the Tentative Phosphorylation Responses
Because of the complexity of the analysis of the quantitative data, one tentative phosphopeptide response was selected for manual inspection (K.VFLQDSVDS*E.-, which is from Gm12250, interferon--inducible p47 GTPase). This phosphopeptide was one of the fifteen that were identified as tentative biomarkers by all three sets of ANOVA analyses (Fig. 5) . Both +1 and +2 charge state ions of this phosphopeptide were confidently identified, and the +1 charge state ion (theoretical m/z = 1218.49259) was manually examined by using Xcalibur Qual Browser (Thermo Fisher Scientific, Inc.) to produce selected ion chromatograms (SICs) from all 46 of the .RAW LTQ-Orbitrap data files (precursor ion mass filtration was +/-10 ppm about the theoretical m/z). This phosphopeptide was the tallest peak in almost all of the SICs, and it had a retention time between 50 -59 min. Note that the y-axis of each SIC was normalized to the height of the tallest peak, and that the normalization level (NL) is indicated to the right of each SIC. The peak heights from the SICs were plotted versus the (not globally normalized) MultiAlign peak areas (Supplemental Table 4 ). The plot clearly shows that the analysis of the quantitative data correctly discovered this tentative signaling response.
Supplemental Protocol Day 0 Mouse Work
Sixty mice were purchased from The Jackson Laboratory (Bar Harbor, ME; http://www.jax.org/) and were strain DBA/2J (Stock Number 000671), female, 8 weeks of age, 5 mice per cage, 12 cages total. One cage of five mice were chosen to be "Day0 Uninjected Negative Control Mice 1 -5" (these mice were not injected with anything at all). Sample tubes were labeled with a unique mouse identifier (i.e., "Day0 Control1", "Day0 Control2", "Day0 Control3", "Day0 Control4", "Day0 Control5") and the name of the tissue/fluid to be stored in them. They were prepped by:
1. Terminal bleed from orbital sinus using a glass Pasteur pipette. The blood (~300-400µl) was pipetted into a microcentrifuge tube that contained 20µl 200mM EDTA (~10mM EDTA final conc.), and the contents were mixed by gently flicking the tube.
2. Cervical dislocation. Mouse sprayed with 70% (v/v) EtOH over site of dissection.
3. Spleen dissected, placed in a 2ml cryovial (Nalgene sterile 2ml cryogenic vial, Thermo Fisher Scientific, Rochester, NY, cat# 5000-0020), immediately snap frozen in Liq. N 2 , stored on dry ice.
4. Kidneys dissected, both placed in a 2ml cryovial, snap frozen in Liq. N 2 , stored on dry ice.
5. Heart dissected, placed in a 2ml cryovial, snap frozen in Liq. N 2 , stored on dry ice.
6. Lungs dissected, placed in a 2ml cryovial, snap frozen in Liq. N 2 , stored on dry ice.
7. Liver dissected, placed in a 20ml scintillation vial, snap frozen in Liq. N 2 , stored on dry ice.
After the blood samples were collected from all five mice, they were microcentrifuged gently at 900g 15min 4°C. The supernatants were pipetted into fresh microcentrifuge tubes, and then the pellets and supernatants were snap frozen in Liq. N 2 and stored on dry ice.
At t=0h and using BSL-2 safety protocols, the remaining 55 mice were injected (intraperitoneal injections) with either ; 25 mice to be Day 1-3 / Sterne 1-5) (10 extra mice were prepared because it was expected that some of them would die before day3).
These mice were then left in their cages overnight. The tissue/fluid samples from the five "Day 0 Uninjected Control 1-5" mice were transferred on dry ice to a freezer and stored at -80°C.
Day 1 Mouse Work
At t=24h, the Day1 mice were bled/dissected/etc. as described above (15 mice total: Sterile H 2 O Control 1-5, ΔSterne 1-5, and Sterne 1-5). All of the mice looked normal except for three mice (Sterne 3-5) that looked sick and their blood was thick and displayed hemolysis (this is not unusual for Day 1 Sterne infected mice).
Day 2 Mouse Work
At t=48h, the Day2 mice were bled/dissected/etc. as described above (15 mice total: Sterile H 2 O Control 1-5, ΔSterne 1-5, and Sterne 1-5). All of the "Sterile H 2 O Control" and "ΔSterne" mice looked normal. Three of the "Sterne" mice were found dead in their cages (this is not unusual for Day 2 Sterne infected mice) and were discarded (i.e., they were not bled, dissected, etc.), and the rest looked sick and only small volumes (~100-200µl) of very thick blood could be drawn. The spleens of the sick mice appeared (by visual observation) to be smaller than normal (~50% of the normal volume) and were pale pink (normally they are blood red).
Day 3 Mouse Work
At t=72h, the Day3 mice were bled/dissected/etc. as described above (11 mice total: Sterile H 2 O Control 1-5, ΔSterne 1-5, and Sterne 1). All of the "Sterile H 2 O Control" and "ΔSterne" mice looked normal. All but one of the "Sterne" mice (i.e., 11 of 12) were found dead in their cages (this is not unusual for Day 3 Sterne infected mice) and were discarded (i.e., they were not bled, dissected, etc.). The single living "Sterne" mouse looked sick and only a small volume (~100-200µl) of very thick blood could be drawn.
Tissue Homogenization
The samples were blocked and randomized. Specifically, the samples were organized into sample blocks (by mouse number -i.e., biological replicate), and then randomized (i.e., ordered randomly within each block, see below). The samples were prepared and analyzed in order (by "bID") within these blocks to reduce any possible systematic biases.
Lysis Buffer (50mM tris-HCl pH8, 8M urea, freshly made or from -80°C frozen stock): 33.6g urea, add H 2 O to 66.5ml total volume, add 3.5ml 1M tris-HCl pH8, confirm pH by pipetting 10µl onto a pH strip. Note that urea solutions must be made fresh daily or stored at -80°C because urea in H 2 O forms a reactive product (cyanate) over time (detectable within minutes) that will chemically modify proteins/peptides (it carbamylates N-term, Arg, and Lys). I made 70ml of Lysis Buffer and then aliquoted it (6 aliquots of ~12ml in 15ml tubes stored at -80°C -use one aliquot per sample block).
Each of the samples were homogenized by adding 200µl of Lysis Buffer to each spleen in its cryovial. Then a rubber (rubber-like?) tipped plastic plunger from a disposable syringe (1ml syringe with 26gauge 1/2inch detachable needle, product# 329652, Becton Dickinson and Company) was used as a sample pestle/grinder/whisk. The spleens were ground/whisked into the bottom of the cryovial for ~5min producing a gooey red liquid with a small (~20-40µl) insoluble component which was discarded. An additional 400µl of Lysis Buffer was added to each sample, and then each was pipetted up and down using a 200µl pipette tip and vortexed 1min to further homogenize the sample. The samples (~650µl each) are now BSL-1. BCA protein concentration assays were performed (Thermo Scientific Pierce cat#23227). The samples were stored at -80°C. The leftover tissue homogenates were stored at -80°C.
2. Add 200ng of bovine β-casein (4µl from a 0.05µg/µl solution (380µl Lysis Buffer, 20µl 1µg/µl bovine β-casein)) to serve as a protein standard.
3. Reduce the sample proteins by adding DTT to a final concentration of 10mM (add 3.74µl of 1M DTT, store 1M DTT at -20°C). Bath sonicate the sample 5min at room temperature to assist homogenization. Incubate the sample at 60°C for 30min to denature and reduce the sample proteins.
4. Alkylate the sample proteins by adding iodoacetamide to a final concentration of 50mM (add 37.77µl of freshly made 500mM iodoacetamide, 500mM NH 4 HCO 3 pH 9). Incubate the sample at room temperature for 20min in darkness.
5. Add H 2 O and 500mM NH 4 HCO 3 pH 9 to the sample such that the final urea concentration will be ≤1M and the final NH 4 HCO 3 concentration will be 100mM (add 700µl 500mM NH 4 HCO 3 pH 9, 2384µl H 2 O -the total volume should be 3.5ml). A precipitate will probably form but don't centrifuge the sample.
6. Digest the samples by adding trypsin (1:100 (protein w:w) trypsin:sample) (add 40µl Promega sequencing grade modified trypsin cat#V5113 0.5µg/µl (pool the trypsin -one pool for each sample block)). Incubate the sample overnight (~18h) at 37°C (the samples actually digested for 21.5h).
7. Acidify the sample by adding acetic acid to a final concentration of 2% (v/v) (add 73µl 100% (v/v) acetic acid stock solution) (the solution will release a gas (CO 2 ?) when mixed). Confirm that the sample is pH ~4 by pipetting 1µl onto a pH strip.
8. Add 8pmol P-AngII (8µl 1pmol/µl phosphorylated angiotensin II) to serve as a peptide standard. The samples were stored at -80°C.
Sep-Pak C-18 SPE
9. Clean up the sample using a Sep-Pak C-18 SPE column ("Vac C18 1cc", cat# WAT023590, Waters Corp., 1ml, 100mg resin). First centrifuge the sample 20min at 2,000g at room temp to pellet particulates (to avoid clogging the SPE column) in a swinging-bucket rotor (Sorvall Heraeus 75006446A) in a table-top centrifuge (Sorvall Legend RT) (in reality it was 40min). Centrifuge the solutions into the Sep-Pak column in a 15ml centrifuge tube in a swinging-bucket rotor (Sorvall Heraeus 75006446A) in a table-top centrifuge (Sorvall Legend RT).
Step
20g 5min 1ml Sample 8 20g 5min ~0.6ml Sample i.e., the remainder of the sample 9 20g 5min 1ml Buffer A 10 20g 5min 1ml Buffer A The samples were yellowish and formed a yellowish band within the top 1/4 -1/3 of the C18 resin. Use a rubber bulb (with a flat opening/interface, intended for use with a glass pasture pipette, Fisher Scientific cat#03-448-25) or a 1ml pipette tip to apply pressure to push Buffer B through the resin: a. Apply 500µl Buffer B (slowly) to elute the sample into a fresh microcentrifuge tube. Note: The yellowish band migrated off the resin. b. Apply 500µl Buffer B (slowly) to elute any remaining sample 10. Concentrate the sample in a SpeedVac (no heat) to ~150µl (~80min). Store the sample at -80°C.
Titansphere TiO 2 SPE
11. Use a TiO 2 pipette tip (Titansphere PHOS-TiO Centrifuge Pipette Tip, 200µl, 3mg TiO 2 resin, 96/pkg, USA Order# 1404096, GL Sciences Japan Part# 5010-21306; Centrifuge Adaptor for PHOSTiO Spin Columns (for both 10µl and 200µl tips), 24/pkg, USA Order# 140001, GL Sciences Japan Part# 5010-21514; GL Sciences, Inc. USA, http://www.inertsil.com/) to enrich phosphopeptides (modified from Thingholm et al 2006 Nature Protocols 1(4):1929-35). These TiO 2 pipette tips are (apparently) constructed with 3mg of TiO 2 resin (same as Titansphere 5µm TiO 2 loose media, 500mg, USA Order# 1400B500, GL Sciences Japan Part# 5020-75000, GL Sciences Inc., Japan) sandwiched between C8 membrane (Empore C8 Bonded Silica Disk, Stock# 98060402140 (47mm) 98060402157 (90mm), 3M Corp.). Add 150µl of TiO 2 Loading Buffer (5% (v/v) TFA, 80% (v/v) ACN, 225mg/ml DHB) to the sample (which should be ~150µl -i.e., add an equal volume of TiO 2 Loading Buffer to the sample). Microcentrifuge the sample 10min at 16,000g to pellet any particulates which might clog the TiO 2 tip. Using a TiO 2 pipette tip inserted into a centrifuge adaptor inserted into a 1.5ml or 2ml microcentrifuge tube (with a hole in the bottom except if flowthru or eluate is to be recovered; without a hole, a 1.5ml tube can hold 100µl without it touching the bottom of the TiO 2 tip, and a 2ml tube can hold 300µl) inserted into a 15ml centrifuge tube. Spin the samples in a swinging-bucket rotor (Sorvall Heraeus 75006446A) in a table-top centrifuge (Sorvall Legend RT). The 15ml tube can be used to collect the waste fluid. Be sure that the swinging bucket can rotate without the sample hitting the rotor. Be careful not to mix Buffer A1 and Buffer B -it smokes and turns green! Step Note: Make the solutions that contain DHB (TiO 2 Loading Buffer and Buffer A1) fresh because they seem to change color (turn brown) after a few weeks.
Note: In a subsequent phosphoproteomics experiment using two other mouse spleen samples, this TiO 2 SPE was performed except that steps 4, 5, 10-15, and 19-22 were skipped, steps 23-25 were performed as a single step (10min, 150µl), and steps 26-28 were performed as a single step (10min, 150µl). Based on the number of confident SEQUEST phosphopeptide identifications, this simplified protocol performed as well as the full protocol.
12. Do not leave the sample in alkaline conditions because pS and pT are alkali-labile (pY is alkalilabile too?) (Buffer B is pH ~12, Buffer A2 is pH ~2, I actually don't know what the pH of the final eluate is). Concentrate the sample in a SpeedVac (no heat) to ~20µl (~60min) to evaporate ACN and NH 4 OH. Acidify the sample by adding 60µl 1% (v/v) acetic acid. Store the sample at -80°C.
Load the sample onto the column/tip using a pressure cell at 1200 PSI N 2 (let the column/tip go dry -it seems to be ok). Measure the volume of the flow-through using a calibrated micropipette to confirm that the whole sample loaded. Note that because the sample was manually loaded in this manner, the phosphopeptides were never exposed to metal (e.g., iron in metal tubing, needles, or valves common to autosamplers -phosphopeptides are known to bind to some metals) or other surfaces that might cause sample loss.
Attach the column/tip to an LC-MS and wash the column/tip ~5min with Buffer A at ~500nl/min constant post-split flow (~110bar, ~110µl/min pre-split) and check for leaks. Reduce LC flow rate to ~350nl/min post-split (~70bar, ~70µl/min pre-split), wait for the back pressure to stabilize (~2min), and measure the post-split flow rate through the column/tip using a calibrated micropipette. Try to achieve a post-split flow rate of ~350nl/min (200nl/min -500nl/min; too low (<~200nl/min) ruins the gradient; 330nl/min -400nl/min seems to work best). Apply 2kV ESI voltage and observe the ESI spray. Set the autosampler to draw H 2 O (it has to be set to draw up something, but the H 2 O just goes to a waste bottle -it's not connected to the column/tip). Elute the analyte using a 120min linear gradient (10-40%B) at ~350nl/min constant post-split flow. Be sure that the .RAW output file will be less than 2GB and that the hard drive has space for it (a typical phosphoproteomics sample analyzed 150min on an LTQ-Orb = ~800MB (1.3GB max; the more complex the sample, the larger the file; some software can't handle files larger than 2GB). After the gradient, regenerate the column/tip by washing it ≥30min with Buffer B and then equilibrating it ≥15min with Buffer A (~500nl/min constant post-split flow).
The LTQ-Orbitrap was calibrated and tuned and new column/tips were prepared as indicated below.
The date (MMDDYY) at the beginning of the filenames (listed below) indicates the day the LC-MS run was initiated. Next, the number indicates the LC-MS run order (e.g., 01, 02, 03, ...), and the letter indicates the column/tip (e.g., a, b). Next is the Sample Name and then the bID. For example, "081409_36bSpleenD2S4b406_200ngBetaCasein_Trypsin_8pmolAngIIP_TiO2_1pmolAngI_LTQ-Orb.RAW"
indicates that this LC-MS run was initiated on Aug 14, 2009, that this was the 36 th run, that it used column/tip b, and that it was SpleenD2S4 (b4-06).
These LC-LTQ-Orbitrap-MS(/MS) runs were performed in the order indicated below, using the indicated column/tips, and without any samples run in between them (i.e., no other samples were run using these column/tips). The mass error of the Orbitrap was always <5ppm (i.e., it didn't require calibration) unless otherwise noted -this was determined from the observed masses of the peptide standards. 
